NCT02229344View on ClinicalTrials.gov

Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea

CompletedOBSERVATIONAL
Enrollment

368

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

February 22, 2022

Study Completion Date

February 22, 2022

Conditions
Colitis, Ulcerative
Interventions
OTHER

No Intervention

Participants with newly diagnosed moderate to severe ulcerative colitis in a tertiary referral hospital within 4 weeks before prior to enrollment will be observed.

Trial Locations (15)

Unknown

Ansan-si

Busan

Cheonan

Cheongju-si

Daegu

Daejeon

Guri-si

Gwangju

Iksan

Incheon

Kwanju

Seongnam-si

Seoul

Suwon

Wŏnju

All Listed Sponsors
lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT02229344 - Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea | Biotech Hunter | Biotech Hunter